Immunotherapy using inhibin antiserum enhanced the efficacy of equine chorionic gonadotropin on superovulation in major inbred and outbred mice strains

Immunotherapy using inhibin antiserum enhanced the efficacy of equine chorionic gonadotropin on superovulation in major inbred and outbred mice strains

Accepted Manuscript Immunotherapy using inhibin antiserum enhanced the efficacy of equine chorionic gonadotropin on superovulation in major inbred and...

1MB Sizes 0 Downloads 32 Views

Accepted Manuscript Immunotherapy using inhibin antiserum enhanced the efficacy of equine chorionic gonadotropin on superovulation in major inbred and outbred mice strains Toru Takeo, Naomi Nakagata PII:

S0093-691X(16)30119-4

DOI:

10.1016/j.theriogenology.2016.04.076

Reference:

THE 13656

To appear in:

Theriogenology

Received Date: 3 February 2016 Revised Date:

25 April 2016

Accepted Date: 25 April 2016

Please cite this article as: Takeo T, Nakagata N, Immunotherapy using inhibin antiserum enhanced the efficacy of equine chorionic gonadotropin on superovulation in major inbred and outbred mice strains, Theriogenology (2016), doi: 10.1016/j.theriogenology.2016.04.076. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT

New superovulation technique Inhibin antiserum + Equine chorionic gonadotropin

Inbred mice: A/J, BALB/cByJ, C3HeJ, DBA/2J, FVB/NJ outbred mouse: CD1



No. of ovulated oocytes: 7-29 oocytes

M AN U

SC



RI PT

Conventional superovulation technique Equine chorionic gonadotropin

No. of ovulated oocytes: 24-90 oocytes

AC C

EP

TE D

 Inhibin antiserum improves the superovulation technique.  Coadministration of inhibin antiserum and gonadotropin produces many oocytes.  The effect is effective to major inbred and outbred mouse strains.  The oocytes normally fertilize and develop to offspring.

1

ACCEPTED MANUSCRIPT

Immunotherapy using inhibin antiserum enhanced the efficacy of

2

equine chorionic gonadotropin on superovulation in major inbred and

3

outbred mice strains

RI PT

1

4

Running title: Improvement of superovulation by inhibin antiserum

6

Summary sentence: Coadministration of inhibin antiserum and equine

7

chorionic gonadotropin improves superovulation technique and is very

8

effective in obtaining high number of ovulated oocytes in major inbred

9

and outbred mice strains.

M AN U

SC

5

Key words: Superovulation, inhibin antiserum, equine chorionic

11

gonadotropin, oocytes, mice, embryo production, mouse strain, mouse

12

repository

TE D

10

15

Toru Takeo and Naomi Nakagata

AC C

14

EP

13

16

Division of Reproductive Engineering, Center for Animal Resources and

17

Development (CARD), Kumamoto University, Chuo-ku, Kumamoto,

18

Japan

19 20

Correspondence:

2

ACCEPTED MANUSCRIPT

21

Naomi Nakagata, E-mail: [email protected], Telephone:

22

+81-96-373-6570, Fax: +81-373-6566

RI PT

23

ABSTRACT

25

Improvement of the superovulation technique will help to enhance the

26

efficiency of embryo and animal production. Blocking inhibin using

27

inhibin antiserum (IAS) is known to promote follicular development by

28

increasing the level of follicular stimulating hormone. Previously, we

29

reported that coadministration of IAS and equine chorionic gonadotropin

30

(eCG) produced more than 100 oocytes from a single female C57BL/6

31

mouse at 4 weeks old. The oocytes derived from the IAS + eCG (IASe)

32

treatment were able to fertilize and develop normally into offspring. In this

33

study, we examined the effect of IASe treatment on the numbers of

34

ovulated oocytes in major inbred (A/J, BALB/cByJ, C3HeJ, DBA/2J, and

35

FVB/NJ) and outbred (CD1) mice strains at 4 weeks old. We confirmed

36

the fertilization and developmental ability of the IASe-derived oocytes.

37

IASe treatment ovulated 1.5 to 3.2 times higher numbers of oocytes than

38

eCG treatment alone. The fertilization rate of IASe-derived oocytes was

39

similar to that of eCG-derived oocytes. In vitro and in vivo developmental

40

rates of the embryos derived from IASe was similar to the rates of

AC C

EP

TE D

M AN U

SC

24

3

ACCEPTED MANUSCRIPT

embryos derived from eCG. We have shown that superovulation by IASe

42

is very effective in obtaining high numbers of ovulated oocytes from small

43

numbers of oocyte donor in a number of mice strains. The superovulation

44

technique will contribute to the archiving of cryopreserved embryos of

45

genetically engineered mice using small numbers of donors and has the

46

potential to produce more live animals for rederivation of the archived

47

mouse lines in mouse repositories.

M AN U

48 49

SC

RI PT

41

INTRODUCTION

Mouse repositories that support the production, preservation, and

51

distribution of genetically engineered mice have been established to

52

improve the accessibility of these mice to the scientific community [1].

53

The archived lines of genetically engineered mice are published by the

54

International Mouse Strain Resource (IMSR; http://www.findmice.org/).

55

Researchers can order and obtain mouse lines via the IMSR.

EP

AC C

56

TE D

50

Reproductive technology is a powerful tool to efficiently manage

57

genetically engineered mice in mouse repositories [2]. In vitro fertilization

58

(IVF) using sperm and oocytes harvested from genetically engineered

59

mice can readily produce a huge number of embryos. The embryos can be

60

transferred to recipients to obtain the numbers of offspring required for a

4

ACCEPTED MANUSCRIPT

planned animal experiment or they can be preserved in liquid nitrogen for

62

later use. The application of reproductive techniques for animal production

63

allows the precise management of size and schedule of experiments using

64

genetically engineered mice.

RI PT

61

The number of ovulated oocytes is a bottleneck that impacts the

66

numbers of embryos and animals that can be produced by reproductive

67

technology. It is important, therefore, to increase the number of ovulated

68

oocytes using superovulation techniques, which artificially promote

69

folliculogenesis

70

Superovulation has been used successfully to obtain oocytes for the

71

production of genetically engineered mice [3]. Traditionally, a regimen of

72

equine chorionic gonadotropin (eCG) and human chorionic gonadotropin

73

(hCG) has been used to induce superovulation in mice [4]; however, the

74

response to this technique is known to vary among inbred and hybrid

75

mouse strains [5, 6].

M AN U

induce

ovulation,

by

hormone

treatment.

EP

TE D

and

AC C

76

SC

65

Administration of inhibin antiserum (IAS) has been shown to induce

77

superovulation in several species [7]. IAS neutralized inhibin, which is a

78

non-steroidal hormone that acts on pituitary cells to suppress the

79

production of follicle-stimulating hormone (FSH) [8]. The blocking of

80

inhibin by IAS promoted follicular development by facilitating the

5

ACCEPTED MANUSCRIPT

production of FSH [9, 10]. Recently, we developed a novel superovulation

82

technique by the coadministration of IAS and eCG [11], which yielded

83

more than 100 oocytes from a single female C57BL/6 mouse at 4 weeks

84

old. The ovulated oocytes were fertilized in vitro and live pups developed

85

after IVF and embryo transfer [11]. However, the efficacy of the IAS +

86

eCG (IASe) treatment on female mice of major inbred and outbred strains

87

has not been examined so far.

M AN U

SC

RI PT

81

In this study, we investigated the effect of IASe treatment on the

89

number of ovulated oocytes in major inbred and outbred mouse strains of

90

A/J, BALB/c, C3H, CD1, DBA, and FVB mice. The ovulated oocytes

91

were used for IVF, and the embryos were cultured and transferred to

92

confirm their fertilization and developmental ability.

TE D

88

EP

93

MATERIALS AND METHODS

95

Animals

96

AC C

94

Inbred mouse strains of A/J (SLC, Shizuoka, Japan), BALB/cByJ

97

(CLEA Japan, Tokyo, Japan), C3HeJ (CLEA Japan), DBA/2J (CLEA

98

Japan), and FVB/NJ (CLEA Japan) and an outbred mouse strain of CD1

99

(Charles River Japan, Yokohama, Japan) were purchased and used as

100

donors of sperm (from male mice at 12–15 weeks old) and oocytes (from

6

ACCEPTED MANUSCRIPT

female mice at 4 weeks old). ICR mice (CLEA Japan) at 8–16 weeks old

102

were used as recipients of 2-cell embryos. All the mice were housed in a

103

specific-pathogen-free room under a 12-h dark-light cycle (light from

104

07:00 to 19:00) at a 22 ± 1°C with ad libitum food and water. The Animal

105

Care and Use Committee of the Kumamoto University School of Medicine

106

approved the protocols for the experiments using animals. The mice were

107

properly handled and euthanized by the person who was admitted and

108

directed by the Animal Care and Use Committee of Kumamoto University.

M AN U

SC

RI PT

101

109 110

Medium

IAS was prepared as described previously and preserved at -20oC

112

before use [9, 10]. Sperm were preincubated in a modified Krebs–Ringer

113

bicarbonate solution (TYH) containing 1.0 mg/mL polyvinyl alcohol

114

(Sigma) and 0.75 mM methyl-β-cyclodextrin (Sigma) as sperm

115

preincubation medium [12, 13]. Calcium-enhanced human tubal fluid

116

(mHTF) containing 0.25 mM reduced glutathione (Sigma) was used as

117

fertilization medium [14-16]. Potassium simplex optimized medium

118

(KSOM) was used to handle and culture the 2-cell embryos to the

119

blastocyst stage [17]. All media were prepared and stored at 4oC no longer

120

than 3 months before use. Sperm preincubation medium, fertilization

AC C

EP

TE D

111

7

ACCEPTED MANUSCRIPT

121

medium and embryo culture medium were preincubated in CO2 incubator

122

(5% CO2 and 95% air) at 37oC for 30 min before use.

124

RI PT

123

Superovulation

Superovulation was performed as described in our previous study [11].

126

Briefly, immature female mice at 4 weeks old were administered 7.5 IU

127

eCG (ASKA Pharmaceutical Co. Ltd, Japan) or IASe (mixed solution of

128

0.1 mL IAS and 3.75 IU eCG) intraperitoneally. Forty-eight hours after the

129

injection of eCG or IASe, the mice were administered 7.5 IU hCG (ASKA

130

Pharmaceutical Co. Ltd, Japan) intraperitoneally. At 17 h after hCG

131

administration, the mice were euthanized by cervical dislocation and the

132

oviducts were collected quickly and transferred to a fertilization dish

133

covered with paraffin oil. Under microscopic observation, cumulus–oocyte

134

complexes were collected from the oviducts by dissecting needle and

135

transferred to a 200-µL drop of fertilization medium. The numbers of

136

ovulated oocytes and their ability to be fertilized were examined in each

137

group.

AC C

EP

TE D

M AN U

SC

125

138 139 140

In vitro fertilization Male mice were euthanized by cervical dislocation and the cauda

8

ACCEPTED MANUSCRIPT

epididymides were collected and transferred to a dish of sperm

142

preincubation medium covered with paraffin oil. Aliquots of sperm were

143

collected from the cauda epididymides using a dissecting needle and

144

transferred to a 100-µL drop of sperm preincubation medium. Sperm were

145

preincubated for 60 min to induce capacitation and then added to the

146

fertilization drop containing the cumulus–oocyte complexes and cultured

147

with oocytes at 37°C in an atmosphere containing 5% CO2 for 3 h. The

148

concentration of motile sperm was measured by computer-assisted sperm

149

analysis (IVOS, Hamilton Thorn Inc.) before insemination and then

150

adjusted to 400–800 motile sperm/µL in fertilization medium. At 3 h after

151

insemination, oocytes were washed in three drops of mHTF (80 µL) and

152

the number of ovulated oocytes was examined. At 24 h after insemination,

153

fertilization rates were calculated as the total number of 2-cell embryos

154

divided by the total number of inseminated oocytes multiplied by 100.

156 157

SC

M AN U

TE D

EP

AC C

155

RI PT

141

Embryo culture and transfer To evaluate the development of the 2-cell embryos produced by IVF,

158

we performed embryo culture and transfer. After IVF, the 2-cell embryos

159

were divided into two groups; one that was cultured to the blastocyst stage

160

in a 100-µL drop of KSOM and another that was transferred into the

9

ACCEPTED MANUSCRIPT

oviducts of ICR females (10 embryos/oviduct) on the day a vaginal plug

162

was found (day 1 of pseudopregnancy). Embryos were transferred through

163

the wall of the fallopian tube as described previously [18], and the

164

numbers of offspring were recorded after 19 days.

165

Statistics

SC

166

RI PT

161

Statistical analysis was performed using Prism version 5.0 (GraphPad

168

Software, San Diego, CA.). The results are expressed as the mean ±

169

standard deviation (SD). The results from each group were compared

170

using analysis of variance after arcsine transformation of the percentages;

171

P < 0.05 was considered statistically significant.

172

TE D

M AN U

167

RESULTS

174

Response to superovulation by IASe in inbred and outbred mice

175

strains

AC C

176

EP

173

The IASe treatment increased the number of ovulated oocytes with

177

higher efficiency than the eCG treatment in all strains of inbred mice

178

tested (Table 1); however, the responsiveness to IASe was different among

179

the strains (A/J, FVB, CD1 < DBA/2J < C3H/HeJ < BALB/cByJ).

180

BALB/cByJ mice ovulated the highest number of IASe-derived oocytes

10

ACCEPTED MANUSCRIPT

(eCG: 29.3±8.9 vs. IASe: 90.3±14.5). A/J mice ovulated the lowest

182

number of both eCG- and IASe-derived oocytes, but the IASe treatment

183

still produced three times more oocytes than the eCG treatment (eCG:

184

7.2±2.7 vs. IASe: 25.5±8.4).

RI PT

181

185

Fertilization ability of the IASe-derived oocytes in inbred and outbred

187

mice strains

M AN U

SC

186

The fertilization rate of IASe-derived oocytes was equal to the

189

fertilization rate of eCG-derived oocytes in all strains of mice tested (Table

190

2).

191

TE D

188

In vitro developmental ability of embryos derived from inbred and

193

outbred mice strains ovulated by IASe treatment

EP

192

Two-cell embryos derived from the IASe treatment developed

195

normally to blastocysts in all strains tested (Table 3). There is no

196

significant difference of the developmental rates of the 2-cell embryos to

197

four-cell embryos, morulae, or blastocysts between eCG and IASe in all

198

groups. More than 90% of 2-cell embryos from C3H/HeJ, DBA/2J, A/J,

199

and CD1 developed into blastocysts. Two-cell embryos from FVB/NJ and

200

BALB/cByJ had lower developmental rates than those from the other mice

AC C

194

11

ACCEPTED MANUSCRIPT

201

strains.

202

Offspring derived from various inbred mice strains ovulated by IASe

RI PT

203

Two-cell embryos derived from the IASe treatment in all the strains

205

developed normally into pups (Table 4). Developmental rates of the 2-cell

206

embryos into pups were no significant difference between eCG and IASe.

207

The rates varied among the mice strains; CD1 had the highest

208

developmental rates and A/J had the lowest developmental rates.

M AN U

SC

204

209 210

DISCUSSION

In the present study, we demonstrated IASe-induced superovulation in

212

various inbred (A/J, BALB/cByJ, C3HeJ, DBA/2J and FVB/NJ) and

213

outbred (CD1) mice strains. The efficacy of IASe on the numbers of

214

ovulated oocytes was 1.5 to 3.2 times higher than eCG alone. The

215

fertilizing and developmental abilities of the IASe-derived oocytes were

216

similar to those of the eCG-derived oocytes. We have shown that

217

superovulation using IASe can be used to improve the efficiency of

218

producing embryos and pups of genetically engineered mice of various

219

inbred and outbred mice strains.

220

AC C

EP

TE D

211

Reproductive technology is known to be a practical and strategic tool

12

ACCEPTED MANUSCRIPT

to efficiently carry out research using genetically engineered mice [5]. The

222

required number of mice can be produced by embryo transfer from fresh

223

or cryopreserved embryos derived from IVF; however, if the numbers of

224

ovulated oocytes from oocyte donors are low the numbers of embryos or

225

animals produced will also be low. Our results suggest that the

226

superovulation method using IASe is a very effective way of obtaining

227

high numbers of ovulated oocytes to produce embryos and animals in

228

mice.

M AN U

SC

RI PT

221

Since 1956, gonadotropins have been used for superovulation to obtain

230

mouse oocytes for experimental purpose [19, 20]. The regimen using eCG

231

and hCG (eCG-hCG) has been used widely to induce superovulation in

232

mice. Optimization of the eCG-hCG treatment by adjusting age, weight,

233

hormone doses, and injection timing was reported to enhance the yield of

234

oocytes in various mice strains [6, 21-26]. In 2001, induction of

235

superovulation by neutralizing inhibin using IAS was reported in ddY

236

mice [27]. Ovulation occurred after a single injection of IAS without hCG

237

in ddY mice at the metestrus stage of the estrous cycle. And then, the

238

efficacy of IAS confirmed wild-derived strains of mice [28, 29]. In 2015,

239

we showed that coadministration of eCG and IAS additively increased the

240

number of ovulated oocytes in a female C57BL/6 mouse [11]. Hasegawa

AC C

EP

TE D

229

13

ACCEPTED MANUSCRIPT

et al [30] reported the response to superovulation using IAS was enhanced

242

by chemically adjusting the metestrus stage using two daily injection of

243

progesterone in mature female mice of C57BL/6, BALB/c, ICR, and

244

B6D2F1 strains. The adjustment of female status to the metestrus stage

245

could help increase the yield of oocytes, but it is not practical because five

246

injections (two progesterone injections, two IAS injections, and one hCG

247

injection) are required at different times. In this study, we demonstrated

248

two injections of IASe and hCG produced sufficient numbers of oocytes in

249

various inbred and outbred mice strains at 4 weeks old (Table 1). Higher

250

numbers of ovulated oocytes were obtained from all the IASe-treated mice

251

strains compared with the numbers reported previously using other

252

protocols [5, 6, 30]. It will be interesting to determine whether

253

administration of IASe can effectively induce superovulation in other

254

strains of mice, other rodents, and mammals.

SC

M AN U

TE D

EP

There was the difference of responsiveness to IASe among mice

AC C

255

RI PT

241

256

strains (Table 1). Previously, Spearow et al reported some major genetic

257

differences regulated ovarian responsiveness to gonadotropins and

258

gonadotropins-induced ovulation rate among mice strains [31-34]. These

259

studies demonstrated C57BL/6 strain was high responder to gonadotropins,

260

whereas A/J strain was poor responder to gonadotropins. IASe treatment

14

ACCEPTED MANUSCRIPT

also indicated similar tendency. Folliculogenesis is regulated by the

262

function of hypothalamic-pituitary-ovarian axis and some related

263

hormones such as kisspeptin, gonadotropin releasing hormone (GnRH),

264

FSH, luteinizing hormone (LH), estradiol and progesterone [35]. Further

265

experiment should be carried out to elucidate the strain-dependency of the

266

responsiveness of gonadotropins or inhibin antiserum.

SC

RI PT

261

The doses of IAS (0.1 mL) and eCG (3.75IU) and the age (4 weeks

268

old) of administration were optimized based on our previous study using

269

C57BL/6J female mice [11]. Optimal doses of hormones (IAS, eCG or

270

hCG) or age may be different among the mouse strains. Therefore,

271

optimizing the dose or age will be effective to increase the number of

272

ovulated oocytes by IASe method.

TE D

M AN U

267

The results of our previous study indicated that IASe-derived oocytes

274

had lower fertilization rates than eCG-derived oocytes in C57BL/6 mice

275

[11]. We also found that methyl-β-cyclodextrin and reduced glutathione

276

improved the fertilization ability of sperm and oocytes in mice [13, 16].

277

Methyl-β-cyclodextrin

278

cholesterol efflux [36]. Reduced glutathione and cysteine analogs

279

enhanced the fertilizing ability of oocytes by breaking disulfide bonds in

280

the zona pellucida [16, 37, 38]. In the present study, we found that, after

AC C

EP

273

induced

sperm

capacitation

by

facilitating

15

ACCEPTED MANUSCRIPT

IVF, the ability of IASe-derived oocytes to be fertilized was similar to that

282

of eCG-derived oocytes in all mice strains (Table 2). The reduced

283

glutathione treatment may have helped to recover the fertilizing ability of

284

IASe-derived oocytes.

RI PT

281

Developmental ability of oocytes obtained by IASe treatment was

286

equal to that of eCG treatment in all strains of mice (Table 3 and 4). These

287

results suggest that the IASe method is applicable to produce embryos and

288

animals of various strains of mice alternative to eCG. Previous studies

289

revealed superovulation using the eCG-hCG protocol altered global

290

methylation pattern of DNA in oocyte and gene expression at the

291

blastocyst stage in mice [39, 40]. Additional experiment should be

292

performed to evaluate the quality of IASe-derived oocytes from the point

293

of view of epigenetic modifications.

EP

TE D

M AN U

SC

285

In the Center for Animal Resources and Development of Kumamoto

295

University, we provide a mouse repository service using various mouse

296

reproductive techniques [41]. When the superovulation technique using

297

IASe was introduced into the mouse repository system, high yields of

298

oocytes from oocyte donors were obtained for the purpose of archiving

299

cryopreserved embryos and reanimating genetically engineered mice.

300

Until now, more than 32,000 strains of genetically engineered mice have

AC C

294

16

ACCEPTED MANUSCRIPT

been archived as livestock, cryopreserved embryos, or cryopreserved

302

gametes in mouse repositories [1]. The mouse lines are available via the

303

website of the International Mouse Strain Resource, which is an

304

international collaboration of mouse repositories that supports researchers

305

who use mouse models [42, 43]. The mouse repositories efficiently

306

produce, preserve, and supply quality controlled mouse lines to ensure

307

reproducible experimental results [44]. The superovulation technique

308

described here will contribute to efficiently archiving cryopreserved

309

embryos of genetically engineered mice using a small number of oocyte

310

donors and will produce more live animals for rederivation of the archived

311

mouse lines. Improved superovulation techniques will enhance the

312

accessibility of genetically engineered mice for the scientific community.

TE D

M AN U

SC

RI PT

301

In summary, we demonstrated IASe-induced superovulation and

314

showed that it had higher efficiency of superovulation than eCG-induced

315

superovulation in immature female mice of various inbred and outbred

316

strains. The quality of oocytes derived from the IASe treatment was

317

similar to that of eCG-derived oocytes. Superovulation using IASe has the

318

advantage of maximizing the numbers of ovulated oocyte obtained from

319

oocyte donors and minimizing the numbers of oocyte donors required.

320

Thus, the efficiency of embryo and animal production is improved and the

AC C

EP

313

17

ACCEPTED MANUSCRIPT

number of animals for oocyte donors is reduced, which meets the 3Rs

322

principle (replacement, reduction, and refinement) in animal experiments

323

[45]. We strongly believe that the optimized reproductive technology

324

using IASe provides good practice for animal experiments using

325

genetically engineered mice.

RI PT

321

ACKNOWLEDGEMENTS

M AN U

327

SC

326

We thank Dr Yoshihisa Hasegawa (Kitasato University, Japan) and Dr

329

Gen Watanabe (Tokyo University of Agriculture and Technology, Japan)

330

for invaluable advice and discussions concerning IAS. We also thank

331

Kiyoko Fukumoto, Tomoko Kondo, Yukie Haruguchi, Yumi Takeshita,

332

Yuko Nakamuta, Tomoko Umeno, Shuuji Tsuchiyama, and Ayumi

333

Mukunoki for their technical support and helpful discussions.

EP

TE D

328

334

REFERENCES

336

1.

337

Eppig JT, Motenko H, Richardson JE, Richards-Smith B, Smith CL. The

International Mouse Strain Resource (IMSR): cataloging worldwide mouse and ES

338 339

AC C

335

cell line resources. Mamm Genome 2015; 26:448-455.

2.

Takeo T, Nakagata N. Applicationof Cryotechnology to Establish Efficient Research

340

Infrastructure for Genetically Engineered Mice. Cryobiology and Cryotechnology

341

2015; 61:19-26.

342

3.

343 344 345

Behringer R, Gertsenstein M, Nagy K, Nagy A. INDUCING SUPEROVULATION. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 2014: 95-97.

4.

Fowler RE, Edwards RG. Induction of superovulation and pregnancy in mature mice by gonadotrophins. J Endocrinol 1957; 15:374-384.

18

ACCEPTED MANUSCRIPT

346

5.

347 348

Byers SL, Payson SJ, Taft RA. Performance of ten inbred mouse strains following assisted reproductive technologies (ARTs). Theriogenology 2006; 65:1716-1726.

6.

Luo C, Zuniga J, Edison E, Palla S, Dong W, Parker-Thornburg J. Superovulation

349

strategies for 6 commonly used mouse strains. J Am Assoc Lab Anim Sci 2011;

350

50:471-478. 7.

352 353

Yan L, Li H, Shi Z. Immunization against inhibin improves in vivo and in vitro embryo production. Anim Reprod Sci 2015; 163:1-9.

8.

RI PT

351

Makanji Y, Zhu J, Mishra R, Holmquist C, Wong WP, Schwartz NB, Mayo KE,

354

Woodruff TK. Inhibin at 90: from discovery to clinical application, a historical

355

review. Endocr Rev 2014; 35:747-794. 9.

Kishi H, Okada T, Otsuka M, Watanabe G, Taya K, Sasamoto S. Induction of

SC

356

superovulation by immunoneutralization of endogenous inhibin through the

358

increase in the secretion of follicle-stimulating hormone in the cyclic golden

359

hamster. J Endocrinol 1996; 151:65-75.

360

10.

M AN U

357

Kaneko H, Nakanishi Y, Akagi S, Arai K, Taya K, Watanabe G, Sasamoto S,

361

Hasegawa Y. Immunoneutralization of inhibin and estradiol during the follicular

362

phase of the estrous cycle in cows. Biol Reprod 1995; 53:931-939.

363

11.

Takeo T, Nakagata N. Superovulation using the combined administration of inhibin

364

antiserum and equine chorionic gonadotropin increases the number of ovulated

365

oocytes in C57BL/6 female mice. PLoS One 2015; 10:e0128330. 12.

Toyoda Y, Yokoyama M, Hoshi T. Studies on the fertilization of mouse eggs in vitro.

TE D

366 367

I. In vitro fertilization of eggs by fresh epididymal sperm Jap. J. Anim. Reprod

368

1971; 16:147–151.

369

13.

Takeo T, Hoshii T, Kondo Y, Toyodome H, Arima H, Yamamura K, Irie T, Nakagata N. Methyl-beta-cyclodextrin improves fertilizing ability of C57BL/6 mouse sperm

371

after freezing and thawing by facilitating cholesterol efflux from the cells. Biol

372

Reprod 2008; 78:546-551. 14.

374

fertilization with the use of a medium based on the composition of human tubal

375 376

fluid. Fertil Steril 1985; 44:493-498.

15.

377 378

Kito S, Ohta Y. In vitro fertilization in inbred BALB/c mice II: effects of lactate,

osmolarity and calcium on in vitro capacitation. Zygote 2008; 16:259-270.

16.

379

Takeo T, Nakagata N. Reduced glutathione enhances fertility of frozen/thawed

C57BL/6 mouse sperm after exposure to methyl-beta-cyclodextrin. Biol Reprod

380 381

Quinn P, Kerin JF, Warnes GM. Improved pregnancy rate in human in vitro

AC C

373

EP

370

2011; 85:1066-1072. 17.

Ho Y, Wigglesworth K, Eppig JJ, Schultz RM. Preimplantation development of

382

mouse embryos in KSOM: augmentation by amino acids and analysis of gene

383

expression. Mol Reprod Dev 1995; 41:232-238.

384 385

18.

Nakagata N. [Embryo transfer through the wall of the fallopian tube in mice]. Jikken Dobutsu 1992; 41:387-388.

19

ACCEPTED MANUSCRIPT

19.

387

treated with gonadotrophins. Nature 1956; 177:754-755. 20.

389 390

Freeman and company; 1971. 21.

391 392

22. 23.

Christenson CM, Eleftheriou BE. Dose-dependence of superovulation response in mice to two injections of PMSG. J Reprod Fertil 1972; 29:287-289.

24.

397 398

Wilson ED, Zarrow MX. Comparison of superovulation in the immature mouse and rat. J Reprod Fertil 1962; 3:148-158.

395 396

Zarrow MX, Wilson ED. The influence of age on superovulation in the immature rat and mouse. Endocrinology 1961; 69:851-855.

393 394

Gates AH. Maximizing yield and developmental uniformity of eggs. San Francisco:

RI PT

388

Gates AH. Viability and developmental capacity of eggs from immature mice

Legge M, Sellens MH. Optimization of superovulation in the reproductively mature mouse. J Assist Reprod Genet 1994; 11:312-318.

25.

SC

386

Kolbe T, Landsberger A, Manz S, Na E, Urban I, Michel G. Productivity of superovulated C57BL/6J oocyte donors at different ages. Lab Anim (NY) 2015;

400

44:346-349.

401

26.

M AN U

399

Zarrow MX, Christenson CM, Eleftheriou BE. Strain differences in the ovulatory

402

response of immature mice to PMS and to the pheromonal facilitation of

403

PMS-induced ovulation. Biol Reprod 1971; 4:52-56.

404

27.

Wang H, Herath CB, Xia G, Watanabe G, Taya K. Superovulation, fertilization and

405

in

406

inhibin-neutralizing antiserum. Reproduction 2001; 122:809-816. 28.

embryo

development

in

mice

after

administration

of

an

TE D

407

vitro

Hasegawa A, Mochida K, Matoba S, Yonezawa K, Ohta A, Watanabe G, Taya K,

408

Ogura A. Efficient production of offspring from Japanese wild-derived strains of

409

mice (Mus musculus molossinus) by improved assisted reproductive technologies.

410

Biol Reprod 2012; 86:167, 161-167. 29.

Mochida K, Hasegawa A, Otaka N, Hama D, Furuya T, Yamaguchi M, Ichikawa E,

EP

411

Ijuin M, Taguma K, Hashimoto M, Takashima R, Kadota M, et al. Devising assisted

413

reproductive technologies for wild-derived strains of mice: 37 strains from five

414

subspecies of Mus musculus. PLoS One 2014; 9:e114305.

415

30.

416

Combined with Estrous Cycle Synchronization. Biol Reprod 2015.

31.

419 420

32.

425

Spearow JL. Characterization of genetic differences in hormone-induced ovulation rate in mice. J Reprod Fertil 1988; 82:799-806.

33.

423 424

Spearow JL. Major genes control hormone-induced ovulation rate in mice. J Reprod

Fertil 1988; 82:787-797.

421 422

Hasegawa A, Mochida K, Inoue H, Noda Y, Endo T, Watanabe G, Ogura A.

High-Yield Superovulation in Adult Mice by Anti-Inhibin Serum Treatment

417 418

AC C

412

Spearow JL, Nutson PA, Mailliard WS, Porter M, Barkley M. Mapping genes that control hormone-induced ovulation rate in mice. Biol Reprod 1999; 61:857-872.

34.

Spearow JL, Barkley M. Genetic control of hormone-induced ovulation rate in mice. Biol Reprod 1999; 61:851-856.

20

ACCEPTED MANUSCRIPT

426

35.

427 428

challenges. Nat Med 2008; 14:1197-1213. 36.

429 430

Matzuk MM, Lamb DJ. The biology of infertility: research advances and clinical Choi YH, Toyoda Y. Cyclodextrin removes cholesterol from mouse sperm and induces capacitation in a protein-free medium. Biol Reprod 1998; 59:1328-1333.

37.

Bath ML. Inhibition of in vitro fertilizing capacity of cryopreserved mouse sperm by factors released by damaged sperm, and stimulation by glutathione. PLoS One

432

2010; 5:e9387.

433

38.

RI PT

431

Takeo T, Horikoshi Y, Nakao S, Sakoh K, Ishizuka Y, Tsutsumi A, Fukumoto K, Kondo T, Haruguchi Y, Takeshita Y, Nakamuta Y, Tsuchiyama S, et al. Cysteine

435

analogs with a free thiol group promote fertilization by reducing disulfide bonds in

436

the zona pellucida of mice. Biol Reprod 2015; 92:90.

437

39.

SC

434

Kobayashi H, Sato A, Otsu E, Hiura H, Tomatsu C, Utsunomiya T, Sasaki H, Yaegashi N, Arima T. Aberrant DNA methylation of imprinted loci in sperm from

439

oligospermic patients. Hum Mol Genet 2007; 16:2542-2551.

440

40.

M AN U

438

Huffman SR, Pak Y, Rivera RM. Superovulation induces alterations in the

441

epigenome of zygotes, and results in differences in gene expression at the blastocyst

442

stage in mice. Mol Reprod Dev 2015; 82:207-217.

443

41.

444 445

Nakagata N, Yamamura K. Current activities of CARD as an international core center for mouse resources. Exp Anim 2009; 58:343-350.

42.

Eppig JT, Bult CJ, Kadin JA, Richardson JE, Blake JA, Anagnostopoulos A, Baldarelli RM, Baya M, Beal JS, Bello SM, Boddy WJ, Bradt DW, et al. The Mouse

447

Genome Database (MGD): from genes to mice--a community resource for mouse

448

biology. Nucleic Acids Res 2005; 33:D471-475. 43.

450

(IMSR). Trends Genet 1999; 15:81-82. 44.

452 453 454 455

Lloyd K, Franklin C, Lutz C, Magnuson T. Reproducibility: use mouse biobanks or

EP

451

Eppig JT, Strivens M. Finding a mouse: the International Mouse Strain Resource

lose them. Nature 2015; 522:151-153. 45.

Flecknell P. Replacement, reduction and refinement. ALTEX 2002; 19:73-78.

AC C

449

TE D

446

21

ACCEPTED MANUSCRIPT

Tables

457

TABLE 1 Effect of IASe and eCG treatments on the numbers of

458

ovulated oocytes in inbred and outbred mice strains

459

BALB/cByJ

No. of ovulated oocytes

eCG

20

153

7.7±2.5

IASe

20

497

24.9±8.1*

eCG IASe

C3H/HeJ

eCG IASe

DBA/2J

eCG

FVB/NJ

293

29.3±8.9

10

903

90.3±14.5*

10

286

28.6±8.4

10

520

52.0±18.1*

10

225

22.5±7.8

10

688

68.8±13.6*

eCG

10

168

16.8±3.3

IASe

10

256

25.6±5.9*

eCG

10

202

20.2±8.0

IASe

10

337

33.7±9.9*

EP

CD1

10

TE D

IASe

Average no. of ovulated oocytes/female

SC

A/J

Superovulation

Total no. of oocyte donors

M AN U

Strains

RI PT

456

Average numbers are expressed as the mean ± SD. *P < 0.05 for IASe

461

compared with eCG in each strain.

462 463 464 465 466

AC C

460

22

ACCEPTED MANUSCRIPT

467

TABLE 2 Fertilizing rates of IASe- and eCG-derived oocytes from

468

inbred and outbred mice strains

C3H/HeJ DBA/2J FVB/NJ CD1

472 473 474 475 476

IASe

20

497

eCG

10

293

IASe

10

eCG

136

88.9±15.9

422

84.9±8.5

213

73.4±11.3

903

680

76.4±9.0

10

286

251

87.8±22.6

IASe

10

520

446

85.8±15.5

eCG

10

225

194

86.2±11.0

IASe

10

688

592

86.0±4.5

eCG

10

168

159

94.6±6.7

IASe

10

256

239

93.3±6.6

eCG

10

202

146

72.3±16.0

IASe

10

337

269

79.8±19.6

Fertilization rate is expressed as the mean ± SD.

EP

471

153

AC C

470

20

Fertilization rate (%)

SC

BALB/cByJ

eCG

No. of fertilized eggs

M AN U

A/J

Superovulation

No. of inseminated oocytes

TE D

Strains

Total no. of oocyte donors

RI PT

469

23

ACCEPTED MANUSCRIPT

477

TABLE 3 In vitro developmental ability of embryos derived from

478

IASe treatment in inbred and outbred mice strains

No. of No. of cultured Strains

Superovulation

No. of 4-cell

(%)

2-cell

morulae embryos

DBA/2J

FVB/NJ

100.0±0

IASe

100

97

97.0±2.5

eCG

100

94

94.0±8.7

IASe

100

eCG

482 483 484 485 486

90.3±15.7

95

95.0±0

70

70.0±2.5

90

90.0±5.2

78

78.0±2.9

83

83.0±2.9

68

68.0±6.3

100

100

100.0±0

100

100.0±0

93

93.0±6.3

IASe

100

98

98.0±2.5

97

97.0±5.2

91

91.0±1.4

eCG

100

96

96.0±1.4

92

92.0±4.3

35

35.0±2.5

IASe

100

95

95.0±7.2

86

86.0±6.6

29

29.0±7.5

eCG

100

98

98.0±2.5

95

95.0±0

91

91.0±4.3

eCG

100

100

100.0±0

100

100.0±0

98

98.0±2.5

100

98

98.0±2.5

97

97.0±1.4

94

94.0±1.4

100

99

99.0±1.4

99

99.0±1.4

97

97.0±1.4

EP

Percentages are expressed as the mean ± SD (n = 3–4).

AC C

481

28

85.0±0

IASe

480

96.8±2.5

85

IASe CD1

30

SC

31

(%)

blastocysts

M AN U

C3H/HeJ

31

TE D

BALB/cByJ

eCG

No. of

(%)

embryos A/J

RI PT

479

24

ACCEPTED MANUSCRIPT

487

TABLE 4 In vivo developmental ability of embryos derived from IASe

488

treatment in inbred and outbred mice strains

BALB/cByJ C3H/HeJ

No. of offspring

(%)

eCG

60

10

16.7±7.6

IASe

60

6

10.0±0

eCG

60

16

26.7±7.6

IASe

60

16

26.7±2.9

60

21

35.0±5.0

60

16

26.7±5.8

60

23

38.3±10.4

60

19

31.7±5.8

60

26

43.3±5.8

60

27

45.0±8.7

eCG

60

30

50.0±8.7

IASe

60

31

51.7±2.9

eCG IASe

DBA/2J

eCG IASe

FVB/NJ

eCG

CD1

EP

Percentages are expressed as the mean ± SD (n = 3).

AC C

490

TE D

IASe

SC

A/J

Superovulation

No. of transferred 2-cell embryos

M AN U

Strains

RI PT

489